M. Schlichting
Impact in
-
- Bone health and osteoporosis research
-
- Vitamin D Research Studies
- Genetic factors in colorectal cancer
Papers in
- Oncology 17
- Colorectal Cancer Treatments and Studies 11
- Polyomavirus and related diseases 4
- Cancer Treatment and Pharmacology 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Co-authors
- Carsten Bokemeyerİ. ÇelikFilippo de BraudJ.T. HartmannIgor BondarenkoP. KoralewskiGunter SchuchAngela Zubel
- Journals
- Annals of Oncology (10 papers)Journal of Clinical Oncology (6 papers)Value in Health (2 papers)Osteoporosis International (1 paper)Dermatology (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
M. Schlichting
20 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Orthopedics and Sports Medicine 296
- Pathology and Forensic Medicine 604
- Oncology 847
- Hepatology 241
- Pulmonary and Respiratory Medicine 374
Countries citing papers authored by M. Schlichting
This map shows the geographic impact of M. Schlichting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Schlichting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Schlichting more than expected).
Fields of papers citing papers by M. Schlichting
This network shows the impact of papers produced by M. Schlichting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Schlichting. The network helps show where M. Schlichting may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Schlichting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2019 | 1 | |
| 4 | 2018 | 1 | |
| 5 | 2017 | 5 | |
| 6 | 2017 | 0 | |
| 7 | 2016 | 18 | |
| 8 | 2012 | 1 | |
| 9 | Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study Hit paper breakdown → | 2011 | 612 |
| 10 | 2011 | 37 | |
| 11 | 2011 | 11 | |
| 12 | 2011 | 8 | |
| 13 | 2011 | 1 | |
| 14 | 2010 | 65 | |
| 15 | 2009 | 63 | |
| 16 | The crystal study: Assessment of the predictive value of KRAS status on clinical outcome in patients with mcrc receiving first-line treatment with cetuximab or cetuximab plus folfiri | 2008 | 11 |
| 17 | 2005 | 6 | |
| 18 | 2003 | 5 | |
| 19 | 2002 | 409 | |
| 20 | The blood picture of 200 Thoroughbreds. | 1956 | 1 |
About M. Schlichting
M. Schlichting is a scholar working on Oncology, Hepatology, Otorhinolaryngology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (11 papers), Lung Cancer Treatments and Mutations (7 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Polyomavirus and related diseases (4 papers), Bacteriophages and microbial interactions (3 papers), Plant Virus Research Studies (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (296 citations), Pathology and Forensic Medicine (604 citations), Oncology (847 citations), Hepatology (241 citations) and Pulmonary and Respiratory Medicine (374 citations). M. Schlichting has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Carsten Bokemeyer, İ. Çelik, Filippo de Braud, J.T. Hartmann, Igor Bondarenko, P. Koralewski, Gunter Schuch, Angela Zubel, S Arnaud and E. Paris. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Value in Health, Osteoporosis International and Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.